Document is current
Any future updates will be listed below
-
Authors
Elnaggar, Mohamed
Mansinho, Joana Nunes
Malkin, Samuel J. P. https://orcid.org/0000-0003-1306-7784
Whitaker, Joseph
Hunt, Barnaby
Glah, Divina
MacLellan, Martina
Ali, Samina
-
Funding
Funding for this research was provided by:
Novo Nordisk Ltd
- License Information
-
More Information
Article History
Received: 11 November 2024
Accepted: 8 January 2025
First Online: 19 February 2025
Declarations
:
: Mohamed Elnaggar has received funds for talks, research grants, and advisory boards from Abbott, Amarin, Amgen, AstraZeneca, Boehringer Ingelheim, Daiichi-Sankyo, Eli Lilly, Menarini, Novartis, Novo Nordisk, and Sanofi. Joana Nunes Mansinho, Joseph Whitaker, Divina Glah and Martina MacLellan are employees of Novo Nordisk Ltd. Samuel JP Malkin and Barnaby Hunt are employees of Ossian Health Economics and Communications, which received consulting fees from Novo Nordisk Ltd to support preparation of the analysis. Samina Ali has received honorarium from Abbott, AstraZeneca, Boehringer Ingelheim, Eli Lilly, and Menarini.
: This article is based on previously conducted studies and does not contain any studies with human participants or animals performed by any of the authors.
